Fierce Pharma

MAY 9, 2024

Five months out from their twin FDA approvals in sickle cell disease (SCD), who’s winning the race to treat patients with their respective gene therapies—bluebird bio or partners Vertex Pharmaceuti | Five months out from their twin FDA approvals in sickle cell disease (SCD), who’s winning the race to treat patients with their respective gene therapies—bluebird bio or partners Vertex Pharmaceuticals and CRISPR Therapeutics?

Leads 270

Leads Patients FDA Pharmaceutical 270

MedCity News

MAY 9, 2024

A Q&A with Naoki Okamura revealed that when it comes to cell and gene therapies, the CEO of Astellas Pharma believes risk-taking is a must for eventual success. The post Astellas CEO Q&A (Part 1): There Is No Playbook on Cell and Gene Therapies appeared first on MedCity News.

Pharma 119

Pharma Biopharma 119

Fierce Pharma

MAY 9, 2024

After telegraphing more than a hundred potential layoffs in March in connection with plans to stop construction of a massive Seagen facility, Pfizer is plowing ahead with efforts to streamline its | Pfizer has proposed another round of staff reductions and role changes at legacy Seagen, this time hitting Seagen’s European headquarters in Switzerland, where 74 positions could be up for the chop.

264

264

MedCity News

MAY 9, 2024

On Wednesday, Ascension noticed that a hacker had infiltrated its systems. As the health system works with Mandiant to investigate the incident, clinical services remain disrupted at Ascension facilities across several states. The post Ascension Hospitals Across Several States Are Offline Following Cyberattack appeared first on MedCity News.

117

117

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

MAY 9, 2024

While Merck & Co.’s Keytruda already boasts a pair of approvals to treat certain forms of endometrial cancer, a recent effort to prove the PD-1 inhibitor’s worth as a post-surgery add-on therap | While Merck & Co.’s Keytruda already boasts a pair of approvals to treat certain forms of endometrial cancer, a recent effort to prove the PD-1 inhibitor’s worth as a post-surgery add-on therapy in newly diagnosed patients has fallen short.

Patients 264

Patients 264

European Pharmaceutical Review

MAY 9, 2024

Withdrawal of the marketing authorisation for the COVID-19 vaccine (ChAdOx1-S [recombinant]) Vaxzevria (SRD) by the European Medicines Agency on 7 May, follows a request by AstraZeneca. “Global demand for all COVID vaccines is now much lower and overall supply exceeds demand. This is in marked contrast to the early part of the pandemic when supply was limited and distribution very limited, especially in poorer countries.

Distribution 110

Distribution Manufacturing Medicine Pharmaceutical 110

Pharmaceutical Commerce

MAY 9, 2024

In an interview with Pharma Commerce Editor Nicholas Saraceno, Cathy O'Brien, VP of Sales, UPS Healthcare discusses her masterclass on delivering agility in supply chains by building a multimodal cold chain network while also reducing risks at LogiPharma Europe 2024.

Networking 105

Networking Sales Pharma Healthcare 105

Fierce Pharma

MAY 9, 2024

In response to rapidly declining profits and the downfall of ADHD drug Vyvanse, Takeda is planning to throw 140 billion Japanese yen ($899 million) toward a company-wide restructuring campaign. | In a multi-year overhaul, the Japanese drugmaker plans to prioritize "organizational agility," procurement savings and tech efficiencies. It's all part of an effort to boost profit margins.

184

184

pharmaphorum

MAY 9, 2024

A UK report has said that inflation and geopolitical instability have led to a “dramatic drop” in investment in smaller companies developing new medicines, with a knock-on effect on the entire life sciences industry.

Medicine 109

Medicine 109

Fierce Pharma

MAY 9, 2024

In the dynamic world of life sciences, digital pathology stands out as a beacon of innovation, promising transformative changes in how pathologists engage, evaluate, and collaborate. | Sitting down with Agilent Technologies, we explore the challenges and opportunities of incorporating digital pathology solutions within companion diagnostics.

130

130

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

MedCity News

MAY 9, 2024

One irony of personalized or precision medicine (PM) is that it aims, against the advice of Hippocrates and Osler, to treat the disease, not the patient. The post Why Personalized Medicine Should Not Be Too Personalized appeared first on MedCity News.

Medicine 107

Medicine Patients Biopharma 107

Fierce Pharma

MAY 9, 2024

Takeda has entered into a restructuring to achieve “organizational simplicity.” Innovent Biologics' GLP-1R/GCGR dual agonist, licensed from Eli Lilly, has notched a second positive phase 3 rea | Takeda launched a restructuring to achieve “organizational simplicity.” Innovent and Eli Lilly's GLP-1R/GCGR dual agonist notched a second positive phase 3 readout.

Biopharma 130

Biopharma Pharma Patients 130

European Pharmaceutical Review

MAY 9, 2024

Regulatory agencies in the US across three sectors: agriculture and environmental, have produced a joint plan to “update, streamline, and clarify” regulations and oversight mechanisms for biotechnology products. The plan, developed by the US Environmental Protection Agency (EPA), the US Food and Drug Administration (FDA), and the US Department of Agriculture (USDA), helps to address US President Biden’s related goals, including and improving the “transparency, predictability, coordination, and

Food and Drug Administration 98

Food and Drug Administration FDA Engineering Consulting 98

Fierce Pharma

MAY 9, 2024

US gene therapy approvals create a big problem for Brazil.

FDA 207

FDA 207

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

ALULA

MAY 9, 2024

In the US alone, 6.2 percent of the total population identify as AANHPI (Asian American, Native Hawaiian, Pacific Islander). May is dedicated to honoring people in the US with AANHPI heritage , so it’s a great time to celebrate their voices and experiences – and to reflect on how we can integrate their stories into our lives all year long , especially with our colleagues and teams.

98

98

MedCity News

MAY 9, 2024

Many consumers leave their provider because of navigation problems, while many leave their insurer because of experience issues, a new Accenture report found. The post Why Consumers Leave Their Payer/Provider appeared first on MedCity News.

Insurance 105

Insurance Patients 105

ALULA

MAY 9, 2024

Welcome back to our series, begun here , on what today’s leaders and workers can learn from AA and NHPI people whose work demonstrates a profound commitment to behaviors with a lasting positive impact.

98

98

pharmaphorum

MAY 9, 2024

A new metric developed by Phesi can predict the burden that clinical trials will impose on patients, allowing amendments that can improve the design, efficiency and cost

Patients 100

Patients 100

Advertisement

ALULA

MAY 9, 2024

It was an honor to explore the story of Nainoa Thompson here , and we’re thrilled you’re following our series on what today’s leaders and workers can learn from AA and NHPI people whose work demonstrates a profound commitment to behaviors with a lasting positive impact.

98

98

pharmaphorum

MAY 9, 2024

Google DeepMind and Isomorphic Labs' newly launched AlphaFold 3 extends the power of the AI model to 'all life’s molecules'

109

109

ALULA

MAY 9, 2024

We enjoyed exploring the story of Shuji Nakamura here , and we’re grateful to you for reading our series on what today’s leaders and workers can learn from AA and NHPI people whose work demonstrates a profound commitment to behaviors with a lasting positive impact.

97

97

Pharmaceutical Technology

MAY 9, 2024

Anixa Biosciences has expanded its partnership with Cleveland Clinic to develop additional vaccines for cancers.

98

98

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

PharmaTimes

MAY 9, 2024

The subtype accounts for 20% of all T-cell leukaemias, a rare form of blood cancer which produces too many abnormal T-cells

Patients 93

Patients 93

PharmaTech

MAY 9, 2024

A greater understanding of molecular and cellular biology and technological advancements are revolutionizing the field of biologics.

72

72

PharmaTimes

MAY 9, 2024

Anticancer drugs will be responsible for 90% of nearly 612,000 predicted US cancer deaths in 2024

Pharma 102

Pharma 102

PharmaTech

MAY 9, 2024

Tara Dougal, content director, Pharma, Informa Markets, discusses successes and insights from this year’s CPHI North America and the agenda for the upcoming CPHI Milan.

Pharma 59

Pharma Marketing 59

Advertisement

Distribution

Pharmaceutical Commerce

MAY 9, 2024

The latest news for pharma industry insiders.

Pharma 105

Pharma Prescription 105

pharmaphorum

MAY 9, 2024

NICE updates guidance on tumour profiling tests to steer adjuvant chemotherapy decisions to include lymph node-positive early breast cancer.

64

64

PharmExec

MAY 9, 2024

In this Pharmaceutical Executive video interview, Panna Sharma, CEO, Lantern Pharma, talks about ensuring global access to LP-284, particularly in regions with limited resources

Pharma 52

Pharma Pharmaceutical 52

Vodori

MAY 9, 2024

Adding a new claim to your campaign requires careful handling to ensure it's not only medically sound but also fits well with your campaign's goals. This guide will walk you through seven crucial steps to evaluate, fine-tune, and smoothly integrate new claims. From gauging relevance to assessing value, confirming reliability, and crafting clear messages, each step plays a vital role in shaping the outcome and effectiveness of your campaign.

Medical 52

Medical Marketing 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales